Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Open in API
Filings indexed 2,023 across all filing types
Latest filing 2019-03-13 Major Shareholding Noti…
Country BE Belgium
Listing BR UCB

About UCB

https://www.ucb.com/

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
190313- Notification de transparence communique de presse v2.pdf
Major Shareholding Notification Classification · 98% confidence The document is titled "Déclaration de transparence UCB SA" and explicitly references compliance with Article 14 of the law regarding the disclosure of significant shareholdings ("publicité des participations importantes"). It details changes in voting rights and financial instruments held by UCB SA and its related entities, specifically noting that a threshold of 3% was crossed on March 8, 2019. This content directly corresponds to regulatory filings concerning changes in major share ownership thresholds. Among the provided codes, 'Major Shareholding Notification' (MRQ) is the most appropriate classification for reporting changes in significant share ownership levels that cross regulatory thresholds.
2019-03-13 French
190313- Transparantieverklaring persbericht v2.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 99% confidence The document is titled "Transparantieverklaring UCB NV" (Transparency Declaration UCB NV) and explicitly mentions the disclosure of important shareholdings ("belangrijke deelnemingen") based on Belgian law (Wet van 2 mei 2007). It details changes in the number of voting rights and financial instruments held by UCB NV and its affiliates, crossing the 3% threshold. This type of filing, which reports changes in significant share ownership, directly corresponds to the definition of Major Shareholding Notification (MRQ). Although it is a regulatory disclosure, MRQ is more specific than the general RNS category.
2019-03-13 Dutch
2018 integrated report - ENG.pdf
Annual Report Classification · 100% confidence The document is titled 'Integrated Annual Report 2018' and contains comprehensive sections including a letter to stakeholders, business performance reviews, consolidated financial statements, notes to the financial statements, and a responsibility statement. It is a full-year report covering company activity and financial performance, which aligns with the definition of an Annual Report (10-K). FY 2018
2019-02-28 English
2018 integrated report - FR.pdf
Annual Report Classification · 100% confidence The document is titled 'Rapport annuel 2018 intégré' (Integrated Annual Report 2018) for UCB. It contains a comprehensive table of contents covering strategy, governance, employee data, environmental footprint, and financial statements (including consolidated financial statements and auditor's report). It explicitly states it includes the management report as required by Belgian law. As it is a full annual report containing substantive financial data and analysis, it is classified as an Annual Report (10-K). FY 2018
2019-02-28 French
2018 integrated report - NL.pdf
Annual Report Classification · 100% confidence The document is titled 'Geïntegreerd 2018 Jaarverslag' (Integrated Annual Report 2018) for the company UCB. It contains a comprehensive overview of the company's performance, including a 'Brief aan onze belanghebbenden' (Letter to stakeholders), 'Onze jaarrekening' (Financial statements), 'Geconsolideerde jaarrekening' (Consolidated financial statements), and 'Verslag van de commissaris' (Auditor's report). It covers the full fiscal year 2018 and provides detailed financial and non-financial data, fitting the definition of an Annual Report (10-K equivalent for non-US entities). FY 2018
2019-02-28 Dutch
190130 - Transparency notification press release Blackrock .pdf
Major Shareholding Notification Classification · 98% confidence The document is a 'Transparency notification' from BlackRock, Inc. to UCB SA/NV, detailing a change in shareholding that crossed the 5% threshold on January 24, 2019. This type of filing, which reports personal share transactions by executives or major shareholders crossing regulatory thresholds, directly corresponds to the definition of Director's Dealing (DIRS) or Major Shareholding Notification (MRQ). Since the content explicitly details the crossing of a major shareholding threshold (5%) and lists the exact number of voting rights and financial instruments held by various BlackRock entities, it fits the 'Major Shareholding Notification' category (MRQ) most precisely. It is not an Earnings Release (ER), Annual Report (10-K), or a general Regulatory Filing (RNS), as it is highly specific to ownership changes.
2019-01-30 English

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.